Zoom Videoconferencing ZM stock analysis and is ZM stock a good investment

Monte Rosa’s $100M offering; Alexion to hand back preclinical program to Zealand Pharma

Plus, news about First Wave BioPharma: Monte Rosa’s $100M offering: The molecular glue degrader biotech priced the offering at $4.70 per share $GLUE and expects

May 17, 2024

After Novartis’ Adakveo was pulled in Europe, the UK follows suit

Novartis is pulling Adakveo from the UK market as its clinical benefits no longer outweigh its risks, a month after the Medicines and Healthcare products

February 22, 2024

New dropletronic devices could transform bioengineering and medicine

Oxford University researchers have made a significant step towards realizing a form of ‘biological electricity’ that could be used in a variety of bioengineering and

November 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.